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Abstract
Mutations underlying genetic cardiomyopathies might affect differentiation commitment of resident progenitor cells. Cardiac mesoangioblasts
(cMabs) are multipotent progenitor cells resident in the myocardium. A switch from cardiac to skeletal muscle differentiation has been recently
described in cMabs from b-sarcoglycan-null mice (bSG/), a murine model of genetic myopathy with early myocardial involvement. Although
complementation with bSG gene was inconsequential, knock-in of miRNA669a (missing in bSG/ cMabs) partially rescued the mutation-
induced molecular phenotype. Here, we undertook a detailed evaluation of functional differentiation of bSG/ cMabs and tested the effects of
miRNA669a-induced rescue in vitro. To this end, cMabs were compared with neonatal cardiomyocytes (CMs) and skeletal muscle C2C12 cells,
representative of cardiac and skeletal muscle respectively. Consistent with previous data on molecular patterns, electrophysiological and Ca2+-
handling properties of bSG/ cMabs were closer to C2C12 cells than to CM ones. Nevertheless, subtler aspects, including action potential
contour, Ca2+-spark properties and RyR isoform expression, distinguished bSG/ cMabs from C2C12 cells. Contrary to previous reports,
wild-type cMabs failed to show functional differentiation towards either cell type. Knock-in of miRNA669a in bSG/ cMabs rescued the
wild-type functional phenotype, i.e. it completely prevented development of skeletal muscle functional responses. We conclude that miRNA669a
expression, ablated by bSG deletion, may prevent functional differentiation of cMabs towards the skeletal muscle phenotype.
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Introduction
In spite of the low intrinsic regenerative potential of cardiac muscle,
undifferentiated self-renewing cells, capable of multi-lineage differen-
tiation, can be found within the adult myocardium. The possibility that
such ‘Cardiac Progenitor Cells’ (CPCs) may be particularly prone to
differentiate into cardiomyocytes has received considerable attention
[1–4]. Vessel-associated progenitor cells, named ‘mesoangioblasts’
(Mabs) [5], have been isolated as a resident population from adult
skeletal [6, 7] and cardiac muscle [8]. Cardiac-resident Mabs (cMabs)
are CPCs with a specific markers profile and, despite their association
with vessels, they are reported to spontaneously acquire cardiomyo-
cyte molecular and functional phenotypes when differentiated in vitro
[8, 9]. On the other hand, skeletal mesoangioblasts (skMabs) differ-
entiated into skeletal myotubes when co-cultured with a skeletal cell
line (C2C12), or transfected with skeletal transcriptional regulator
(MyoD) [7]. These observations support the intriguing hypothesis of
a role of tissue-specific factors in committing resident multipotent
cells to their differentiation fate.
b-sarcoglycan (bSG) is a protein of the dystrophin complex with
still undefined functions [10]. bSG-null mouse (bSG/) develops a
skeletal myopathy with early cardiac involvement [11]. We recently
found that cMabs, isolated from the atria and ventricles of bSG/
mice spontaneously differentiate into skeletal myotubes [12], instead
of cardiomyocytes. This surprising observation suggested at first that
bSG itself might act as a differentiation switch. However, further anal-
ysis showed that bSG/ cMabs had deficient expression of homolo-
gous miRNAs, either encoded by a sequence within the bSG gene
(miRNA699q), or silenced at the post-transcriptional level (miR-
NA699a) in bSG/ cMabs. These miRNAs synergically control
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skeletal myogenesis. Whereas restoring wild-type (WT) bSG had only
partial effects, knock-in of miRNA669a was adequate to prevent skel-
etal differentiation of cMabs [12, 13]. In our previous work, aberrant
differentiation in bSG/ cMabs was evaluated mostly in terms of
protein expression patterns with only preliminary reference to func-
tional aspects. The present work undertakes a detailed characteriza-
tion of excitation–contraction coupling in myotubes formed by in vitro
differentiation of murine bSG/ cMabs (bSG/ myotubes). Particu-
lar attention was devoted to the detection of features suggesting
residual myocardial differentiation. To this aim, bSG/ myotubes
were compared, under uniform experimental conditions, to myotubes
formed by a skeletal muscle cell line (C2C12) and to neonatal cardiac
myocytes (CMs). C2C12 cells were used as the skeletal muscle proto-
type for consistency with our previous work on molecular character-
ization of aberrant bSG/ cMabs differentiation [12].
Materials and methods
Cell isolation and culture
cMabs were isolated from WT and bSG/ mice as previously
described [12, 14]. cMabs clones were obtained from ventricle (H4V),
atrium (ATG5) and aorta (AoA4), the number amplification passages at
which WT and bSG/ clones were studied was similar (20  2).
Because AoA4 cMabs (either WT or bSG/) failed to form myotubes
or to show any other sign of differentiation, they were discarded. Func-
tional experiments on cMabs-derived myotubes were performed mainly
on the H4V clone, but similar results were obtained with the ATG5
clone. cMabs and C2C12 cells were amplified in presence of DMEM
20% foetal bovine serum BS and differentiated in 3.5-cm Petri dishes in
presence of low horse serum (2% HS) for 5 days before the experi-
ments [12]. Neonatal (2–5 days p.n.) CMs were isolated from normal
murine hearts as previously described and studied within 1–2 days
from dissociation [15].
Cell-shortening measurement
Cells shortening (twitch) was measured by video edge detection (Cres-
cent Electronics, Salt Lake City, UT, USA) during field stimulation
(2 Hz). Cells were superfused with Tyrode’s solution containing (in
mM): 154 NaCl, 4 KCl, 2CaCl2, 1 MgCl2, 5.5 D-glucose, 5 HEPES
titrated to pH 7.35 with NaOH. Ca2+-free Tyrode’s solution was obtained
by substituting Ca2+ with Mg2+ (3 mM) plus EGTA (1 mM).
Electrophysiological techniques
bSG/ and C2C12 myotubes, and single CM were voltage- or current
clamped in the whole-cell configuration (Axopatch 200-A, Molecular
Devices, Sunnyvale, CA, USA). Pipette (intracellular) solution contained
(mM): 110 K+-Aspartate, 23 KCl, 0.2 CaCl2 (Ca
2+ free = 107 M), 3
MgCl2, 5 HEPES KOH, 0.5 EGTA KOH, 0.4 GTP-Na salt, 5 ATP-Na salt,
5 creatine phosphate Na salt, pH 7.3. In ICaL measurements, intracellular
K+ was replaced by Cs+. Whole-cell series resistance was
5.7  0.3 MΩ and the voltage error caused by their incomplete com-
pensation was 2.4  0.5 mV in the worst case (ICaL recordings); both
variables were similar among experimental groups. For ICaL measure-
ments extracellular K+ was replaced by TEA-Cl.
Current signals were filtered at 2 kHz and digitized at 5 kHz (Axon
Digidata 1200; Molecular Devices). Current density was calculated by
normalization to membrane capacitance (Cm). The voltage dependence
of ICaL steady-state activation (d∞) was estimated from the current–volt-
age relation of peak ICaL (Ipeak) by assuming complete activation and
negligible inactivation at this time-point:
daðV Þ ¼ Ipeak=½Gmax  ðV  Vrev Þ
,where Gmax is the fully activated conductance, V is membrane potential
and Vrev is the current reversal potential. d∞(V) data points were fitted
by Boltzmann functions of the type:
daðV Þ ¼ 1=ð1þ expððV1=2  V Þ=sÞÞ
,where V1/2 is mid-activation potential, and s is the slope factor (in mV).
The time constants (τ) of ICaL inactivation were estimated by mono-
exponential fitting of ICaL decay during the depolarizing step. Trace
acquisition was controlled by a dedicated software (pClamp 8.0; Molec-
ular Devices), analysis was performed by OriginPro 7 (OriginLab Corpo-
ration, Northampton, MA, USA). All recordings were made at 34 
0.5°C. Voltage protocols are described in the figures.
Ca2+ imaging experiments
Cells were incubated with 2 lM of the Ca2+-sensitive dye Fluo4-AM
(Molecular Probes, Paisley, UK) for about 45 min. at room temperature
and then resuspended in Tyrode’s solution for about 15 min. Measure-
ments were performed with a laser-scanning confocal microscope (Leica
TCS SP2; Leica Microsystems, Wetzlar, Germany). Fluo4-AM was excited
with an argon laser at k = 488 nm, and the emitted fluorescence (F) was
detected at k > 512 nm. Changes in intracellular Ca2+ activity were
expressed as changes in the F/F0 ratio (arbitrary units), where F0 is the
mean field fluorescence recorded under baseline conditions. This set of
experiments aimed to assess Ca2+ release from intracellular stores; there-
fore, all measurements were performed during superfusion with Ca2+-free
Tyrode’s solution.
The number of cells in which a given stimulus induced a [Ca]i tran-
sient was measured from bidimensional (xy) images (sampling rate 1.2
Hz) from low magnification fields; the number of responsive cells was
divided by the number of total cells in the field to obtain the percentage
of stimulus responders as previously described [16]. The time course
of [Ca]i changes was obtained from the same images by monitoring flu-
orescence from individual cells in the field. Because of the slow kinetics
of global Ca2+ release events, their time course could be reasonably
defined even at this low sampling rate (Fig. 6).
Spontaneous unitary Ca2+ release events (Ca2+ sparks) were recorded
at 963 magnification in line-scan mode (sampling rate 0.8 kHz).
Images were analysed by SparkMaster (ImageJ) software [17]. Auto-
matic spark detection threshold (criteria) was slightly adjusted accord-
ing to image quality, but was similar among experimental groups
(3.56  0.1, 3.5  0.08 and 3.57  0.11 for bSG/, C2C12 and CM
respectively). The following spark parameters were measured: frequency
(N of events/s*100 lm), amplitude (DF/F0), full width at half-maximal
amplitude (lm, FWHM), full duration at half-maximal amplitude (ms,
FDHM); time to peak (ttp) and decay time constant (τ, monoexp.
fitting).
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Statistical analysis
Results are expressed as mean  SEM; the significance of differences
was tested by unpaired Student t-test for continuous variables and by
the v2 test for categorical ones. Sample size is reported in the figures;
a value of P < 0.05 was considered significant.
Results
Characterization of undifferentiated cMabs
Molecular markers typical of mesoangioblasts [8] were equally
expressed by WT (C3D10 clone) and bSG/ cMabs (Figure S1a).
Early ‘cardiac’ markers (Myocardin and MEF2C) were expressed
in cMabs but also in C2C12 cells (data not shown); therefore,
they should not be considered as indicative of cardiac commit-
ment.
Caffeine- or nicotine-induced whole-cell responses were totally
absent in WT cMabs, occurred in a small percentage of bSG/
cMabs (caffeine 3.1%, nicotine 1.5%) and were even less frequent in
C2C12 cells (caffeine 0.9%, nicotine 0.5%). This indicates the
absence of a muscle-type Ca2+ store in the precursors at the pre-dif-
ferentiation stage. On the other hand, ATP elicited Ca2+ transients
were common even in undifferentiated bSG/ cMabs and C2C12
cells (96.6% and 86.3% respectively). Interestingly, 8–10 days of cul-
ture in differentiating medium were necessary before ATP-induced
Ca2+ transients could be induced in WT cMabs (Figures S1c–S2b), to
indicate the absence of even unspecific responses in undifferentiated
WT cMabs.
Characterization of differentiated cells/myotubes
After culture in differentiating medium for 5 days, both bSG/
cMabs and C2C12 cells fused to form multinucleated myotubes, as
previously described [8].
Membrane capacitance was 110.5  14 pF in WT cMabs
(n = 13), 185.7  18.8 pF in bSG/ myotubes (n = 23),
163.6  12.8 pF in C2C12 myotubes (n = 27) and 44.1  6.6 pF
in CMs (n = 19). Even after 8–10 days of culture in differentiating
medium, WT cMabs failed to form myotubes and remained as
single non-contracting elements (Figure S1b). Preliminary analysis
of their functional properties revealed inexcitability and poorly
polarized membrane (resting Vm = 18.4  2.2 mV, n = 13).
Instantaneous and steady-state I/V relationships showed the
absence of inward components (Figure S3a) and membrane cur-
rent was unresponsive to nicotine (Figure S3b). Although oscillat-
ing spontaneously, cytosolic Ca2+ was unresponsive to caffeine
(Figure S2a). These findings indicate that WT cMabs did not
undergo differentiation; therefore, they were not subjected to the
further functional evaluations aimed to define the differentiation
fate of bSG/ cMabs as compared with that of C2C12 cells and
CMs.
Ca2+ dependency of voltage-triggered contraction
bSG/, C2C12 myotubes and individual CM contracted in response
to electrical field stimulation (2 Hz) (Fig. 1). Extracellular Ca2+ is
strictly required to couple sarcolemmal depolarization to force devel-
opment in cardiac muscle (Ca2+-induced Ca2+ release, CICR), but not
in the skeletal one (voltage-induced Ca2+ release, VICR). This set of
experiments analysed Ca2+ dependency of voltage-triggered contrac-
tion in bSG/ myotubes and compared it with that of C2C12 myotu-
bes and CMs.
After switching to Ca2+-free solution, stimulated cell shortening
persisted almost unchanged for tens of seconds in bSG/ myotubes
(Fig. 1 top) and decayed slowly in C2C12 ones (Fig. 1 middle). On
the other hand, Ca2+ removal almost immediately abolished stimu-
lated shortening in CMs (Fig. 1 bottom). In all cases, cell shortening
at least partially recovered with Ca2+ readmission.
Presence of cholinergically induced contraction
Whereas cholinergic-receptor-operated channels (nicotinic receptors,
nAChR) are highly expressed in skeletal muscle and mediate neurally
induced contraction, cholinergic (muscarinic) receptors in cardiac
muscle are exclusively metabotropic, with a modulatory role. Here,
bSG/ myotubes are compared with C2C12 ones and with CMs in
terms of contractile response to cholinergic stimulation.
The cholinergic agonists nicotine (100 lM) and acethylcholine
(100 lM, data not shown) consistently induced cell shortening in
unstimulated bSG/ and C2C12 myotubes. Nicotine effect was
blocked by the nAChR antagonist d-tubocurarine (100 lM d-TbC;
Fig. 2a and b). Unstimulated CMs failed to respond to nicotine (data
not shown); moreover, the latter had a negligible effect on either
spontaneous or electrically triggered CMs shortening (Fig. 2c). In
both bSG/ and C2C12 myotubes, nicotine repeatedly elicited full-
fledged contractions only if applied at long intervals, as expected from
nAChR desensitization [18].
Within bSG/ cMabs and C2C12 cultures, cells remaining as sin-
gle elements (i.e. not forming myotubes) did not mechanically
respond to nicotine challenge.
Effect of cholinergic stimulation on membrane current and
voltage
In skeletal (but not cardiac) muscle, activation of nAChR induces a
cationic transmembrane current, inward at resting membrane poten-
tials and adequate to trigger action potentials. The effect of nicotine
pulses (100 lM) on membrane current and potential was thus com-
pared between bSG/ and C2C12 myotubes.
Total membrane current was recorded at a holding potential of
80 mV (Fig. 3). Nicotine challenge induced an inward current,
partially decaying during sustained agonist exposure (Fig. 3a and b,
upper records). Peak current density was comparable between
bSG/ and C2C12 myotubes and values were 24.1  4 pA/pF and
35.5  7.3 pA/pF for bSG/ (n = 8) and C2C12 (n = 5) myotubes
respectively (bSG/ versus C2C12, NS).
Under I-clamp conditions (I = 0) nicotine-induced membrane
depolarization (Fig. 3 bottom records in each panel) and triggered
action potentials in bSG/ and C2C12 myotubes (Fig. 3a, lower
ª 2013 The Authors
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record). The effect of nicotine on membrane current and potential
was reversibly blocked by d-tubocurarine in myotubes of both cell
types (Fig. 3a and b).
Action potential analysis
Maturation of both skeletal and cardiac murine action potentials (AP)
is accompanied by hyperpolarization of diastolic potential and short-
ening of AP duration (APD). The plateau phase, the fingerprint of large
mammal’s cardiac AP, largely disappears in mature rodent’s
cardiomyocytes, but it can still be observed in immature ones. This
set of experiments, illustrated in Figure 4, compares action potentials
of bSG/ myotubes, C2C12 myotubes and CMs.
In APs of C2C12 myotubes, repolarization was consistently mono-
tonic; APD90 values were narrowly distributed around a mean of
26  2 msec. (n = 19). In bSG/ myotubes, APD90 was 46 
5 msec. (n = 30; P < 0.05 versus C2C12 and CMs); its distribution,
wide and skewed, also included very high values. The latter corre-
sponded to APs with biphasic repolarization, i.e. displaying a more or
Fig. 1 Dependence of contraction from
extracellular Ca2+. Left: recordings of field-
stimulated cell shortening (twitch, in arbi-
trary units) in bSG/, C2C12 myotubes
and a CM during superfusion of Tyrode’s
solution containing 1.8 mM Ca2+ (Ctr,
black line), 0 mM Ca2++ 1 mM EGTA
(grey line) and return (dot line). Right:
time course of twitch amplitude in the
three experimental conditions.
a
b
c
Fig. 2 Contractile response to cholinergic
stimulation. Cell length recordings in qui-
escent bSG/ (a) and C2C12 (b) myotu-
bes. Nicotine (100 lM)-triggered cell
contractions and their reversible suppres-
sion by the nicotinic receptor antagonist
d-TbC (100 lM). (c) In CMs, nicotine nei-
ther triggered contraction during quies-
cence (right) nor changed the properties
of contractions during electrical stimula-
tion (left).
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less defined ‘plateau’ phase. In CMs, a majority of APs with fast and
monotonic repolarization coexisted with a smaller proportion of
longer APs with a discernible plateau phase; mean CMs APD90 was
29  5 msec. (n = 19; NS versus C2C12).
Diastolic potential (Ediast) was most variable in C2C12 myotubes
and tended to be more positive (63.7  7.6 mV), than in either
bSG/ myotubes (70.6  1.7 mV) or CMs (71.1  1.5 mV).
Because of the scattered values in C2C12 myotubes, analysis of vari-
ance did not detect differences among the three cell types. No corre-
lation was found between APD90 and Ediast values within each cell
type.
Ca2+ current analysis
Faster and more complete inactivation of voltage-activated Ca2+ cur-
rent is a distinctive feature of cardiac muscle as compared with skele-
tal one. Therefore, comparison of ICaL properties may help in defining
the functional phenotype of bSG/ myotubes.
ICaL activation at various potentials was preceded by a 150 msec.
step to 50 mV to inactivate ICaT (holding potential = 90 mV).
Activating steps of either 0.5 or 1 sec. in duration were used to
accommodate the different ICaL kinetics. Membrane capacitance (Cm)
was 180.2  35.5 pF in C2C12 myotubes (n = 9), 117.4  22 pF in
bSG/ myotubes (n = 6) and 48.7  10.4 pF in CMs (n = 9). I/V
curves were obtained by plotting peak current density (Im/Cm) versus
activating potential.
As already evident by gross examination of sample recordings
(Fig. 5a), inactivation kinetics was similar in bSG/ and C2C12
myotubes and differed from that of CMs (also notice the difference
a
b
Fig. 3 Cholinergic modulation of membrane current/voltage. Gap-free
recordings in V-clamp (holding at 80 mV) and I-clamp (I = 0 pA)
modes. In bSG/ (a) and C2C12 (b) myotubes, nicotine (100 lM) elic-
ited inward current, which partially decayed during agonist application,
and was reversibly abolished by d-TbC (100 lM). In I-clamp mode, nic-
otine elicited membrane depolarizations, also reversibly suppressed by
d-TbC, which occasionally triggered full-fledged action potentials in
bSG/ myotubes (a).
Fig. 4 Action potential contour. Top: Representative examples of action potentials recorded during electrical stimulation in C2C12, bSG/ myotubes
and CMs. Bottom: normalized distribution of action potentials durations in the three cell populations. APD90 = action potential duration at 90% repo-
larization; Ediast = diastolic potential, N/Ntot = fraction of observations in each APD90 interval.
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in the timescale). Figure 5b shows that inactivation time constants
(τinact) had a shallow dependency on membrane potential in all cell
types, but were distinctly shorter in CMs (n = 9) than in bSG/
or C2C12 myotubes (P < 0.05 at all potentials, n = 7 and n = 12
respectively).
Peak current I/V relationship (Fig. 5c) was also similar between
bSG/ and C2C12 myotubes, but was shifted towards negative
potentials in CMs. Such a shift was quantified by Boltzman fitting of
‘activation curves’. In bSG/ myotubes (n = 6) V1/2 was similar to
that of C2C12 myotubes (n = 9, 3.4  2.2 mV versus
3.5  1.1 mV, NS), but 6.3  3.1 mV more positive than that of
CMs (9.7  2.2 mV P < 0.05; n = 5); the slope factor was similar
between bSG/ and C2C12 myotubes, but different for CMs
(bSG/ 4.6  0.8 mV; C2C12 5.5  0.2 mV; CM 8  0.4
P < 0.05). Maximal ICaL density was slightly smaller in CMs
(8.3  2.0 pA/pF) than in either bSG/ (10.2  1.6 pA/pF,
P < 0.05) or C2C12 myotubes (11.6  1.5 pA/pF, P < 0.05).
Expression of skeletal (Cav 1.1) versus cardiac (Cav 1.2) Ca
2+
channel mRNAs was studied by PCR. The Cav 1.1 transcript was
equally expressed in C2C12 and bSG/ myotubes, and at a much
lower level in CMs. The Cav 1.2 transcript was detected in CMs only
(Fig. 5e). Immunolabelling of bSG/ myotubes revealed extensive
expression of Cav 1.1. No Cav 1.2 signal could be detected in the
same cell batch (Fig. 5f).
Function of the Ca2+ store
Sarcoplasmic reticulum (SR) function as a Ca2+ store was compared
between bSG/ and C2C12 myotubes. This was achieved by evaluat-
ing whole-cell Ca2+ transients, elicited either by direct modulation of
RyR (caffeine) and IP3R channels (IP3 increased by ATP), or by mem-
brane depolarization (induced by nicotine or high [K+]o). Furthermore,
the properties of Ca2+ sparks occurring in electrically quiescent cells
(spontaneous releases) were studied in the three cell types. To focus
on SR-dependent Ca2+ release, all measurements were carried out in
the absence of extracellular Ca2+ (Ca2+-free solution).
Caffeine and nicotine consistently induced Ca2+ responses in
bSG/ and C2C12 myotubes (Fig. 6a). Therefore, the presence of
Ca2+ responses triggered by nAChR stimulation, and mediated by
RyR channels, can be related to cell differentiation for both precursor
types.
a b
e
f
c
d
Fig. 5 L-type Ca2+ current (ICaL) analysis and channel expression. (a) Representative ICaL recordings in bSG
/, C2C12 myotubes and CMs (voltage
protocol in top panel); (b) V dependency of ICaL inactivation time constants (τinact); (c) Peak ICaL I/V curves (top) and (d) steady-state activation
curves (Boltzman fitting). (e) Expression (RT-PCR) of skeletal (Cav1.1) and cardiac (Cav 1.2) Ca
2+ channel isoforms (GAPDH as reference). Open cir-
cles: C2C12 (N = 9); filled squares: bSG/ (N = 6); filled triangles: CMs (N = 5). (f) Confocal immunofluorescence analysis of Cav 1.1 (skeletal)
and cardiac Cav 1.2 (cardiac) isoforms in bSG/ myotubes. Signals for Cav (green) and nuclei (blue-Hoechst) are superimposed on the light trans-
mission image.
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In both bSG/ and C2C12 myotubes, repeated applications
of either high [K+]o or nicotine-triggered whole-cell Ca
2+ tran-
sients of exponentially decreasing amplitude, as expected from
depletion of the Ca2+ store. Nevertheless, within each cell type,
the decay was faster with nicotine. Neither high [K+]o nor nico-
tine-induced Ca2+ transients in the presence of 30 lM nifedipine
(Fig. 6b), indicating the involvement of Cav channels. Even shortly
after high [K+]o pulses adequate to deplete the store, caffeine still
elicited a large Ca2+ transient. This pattern has been reported for
C2C12 myotubes [19] and interpreted to suggest that the Ca2+
compartment released by caffeine is at least not entirely accessi-
ble to VICR.
The decay of Ca2+ transients amplitude upon repeated high [K+]o
exposure was more complete and distinctly faster in C2C12 than in
bSG/ myotubes, as quantified by the average number of exposures
required for steady-state depletion (2.5  0.4, n = 8 versus
9.4  0.2, n = 12; Fig. 6b).
Representative examples of Ca2+ sparks recordings in the three
cell types are shown in Figure 7. The upper panel shows a 3D
plot, in which normalized fluorescence intensity (amplitude) was
digitized and represented on the vertical axis. Lower panels show
raw-line-scan images (intensity represented by colour scale),
aligned with the respective intensity profiles at the active release
sites. Visual analysis of these examples reveals events with dis-
tinctly different durations; whereas short events prevailed in CMs
and long ones in bSG/ myotubes, C2C12 myotubes were char-
acterized by the presence of both short and long events, appearing
at distinct release sites.
In previous work on skeletal muscle, short and long events have
been classified as ‘sparks’ and ‘embers’, respectively, based on a
FDHM cut-off of 50 msec. [20]. According to this criterion, embers
were significantly represented in bSG/ and C2C12 myotubes (58%
and 53.4% of total events respectively) and infrequent in CMs (21.5%
of total events, P < 0.05 versus bSG/), where FDHM never exceed
60 msec. In bSG/ myotubes the same release site generated both
sparks and embers; this was at variance with C2C12 myotubes, where
each site generated a single class of events (i.e. spark or ember).
Parameters means for all release events are compared between the
three cell types in Table 1. Except for frequency, highest in bSG/
a
b
c
Fig. 6 Intracellular Ca2+ transients. (a)
confocal Ca2+ image ([Ca2+] colour scale
on the right) of a bSG/ myotube field
during exposure to Ca2+-free Tyrode and
after addition of 40 mM extracellular K+
(High K+), 100 lM nicotine or 10 mM caf-
feine. (b) Ca2+ transients elicited by
repeated challenge with high K+ (red
bars), nicotine (white bars) or nicotine
plus nifedipine (green bar) in bSG/ and
C2C12 myotubes. The larger transient at
the end of each record was induced by a
caffeine pulse (bar) to measure SR Ca2+
content; (c) RyR isoforms expression pat-
terns (RT-PCR) in bSG/, C2C12 myotu-
bes and CMs (GAPDH as reference).
Table 1 Properties of elementary Ca
2+ release events
bSG/
(n = 257)
C2C12
(n = 208)
CM
(n = 254)
Amplitude (ΔF/F0) 0.47  0.02 0.49  0.01 1.07  0.03*
FWHM (lm) 3.7  0.1 3.8  0.08 1.8  0.04*
FDHM (ms) 94.5  5.7 92.8  8.7 41.7  1.2*
τ (ms) 125.7  14 120.4  19.3 41.8  1.5*
TTP (ms) 47.3  3.1 55.9  4.2 18.3  0.8*
Frequency
(N/s*100 lm)
3.67  0.44 1.6  0.4* 1.05  0.3*
*P < 0.05 versus bSG/.
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myotubes, all the parameters sharply distinguished CMs events from
those of bSG/ and C2C12 myotubes, which were similar to each
other. In the average, CMs events had larger amplitude, faster kinetics
and smaller width as compared with those of the other cell types. Fur-
ther characterization of elementary Ca2+ release events between the
three cell types may be provided by comparison of distributions of
spark image parameters, provided in the Supplement (Figures S4 and
S5). In summary, means and distribution of spark image parameters
converge in indicating gross similarity of elementary Ca2+ releases
between bSG/ and C2C12 myotubes and a clear-cut difference
between them and CMs; subtler differences were also observed
between bSG/ and C2C12 myotubes.
Expression of RyR isoforms was studied by PCR (Fig. 6c).
Whereas C2C12 myotubes expressed both RyR1 and RyR3
mRNAs, bSG/ myotubes contained exclusively RyR1 transcript.
RyR2, the only isoform found in CMs, was absent from the other
cell types.
Phenotype rescue by miRNA699a transduction
To test whether the WT phenotype could be rescued by re-expression
of the sequence encoding for miRNA699a, bSG/ cMabs were trans-
fected with lentiviral vector containing the sequence (LV-miRNA699a,
Figure S6). Rescued bSG/ cMabs (R-bSG/ cMabs) were sub-
jected to the same differentiation protocol and studied at the same
times as non-transfected ones. R-bSG/ cMabs failed to form myo-
tubes retaining a morphology similar to the wild-type cMabs. Ca2+
responses were evoked by ATP, but these cells were insensitive to
either caffeine or nicotine (Figure S1c).
Discussion
The findings of this study indicate that many functional properties
assimilate bSG/ myotubes to C2C12 ones and, at the same time,
distinguish them from CMs. These properties included: (1) depen-
dency of voltage-triggered contraction on extracellular Ca2+; (2) pres-
ence of cholinergically induced contraction and Ca2+ responses; (3)
membrane current and potential responses to cholinergic stimulation
compatible with a robust expression of receptor-operated channels of
the nicotinic type (blocked by d-tubocurarine); (4) ICaL kinetics and
activation voltage dependency; (5) features of elementary Ca2+ release
events, both in terms of average parameters and of their distribution
patterns (of particular notice, the presence of embers); (6) expression
of Cav 1.1 and RyR1 transcripts, with virtual absence of Cav 1.2 and
RyR2 ones.
bSG/ myotubes displayed many functional properties distinc-
tive of skeletal muscle and, under homogeneous experimental condi-
tions, shared them with myotubes formed by a line of skeletal muscle
precursors (C2C12 cells). This observation is consistent with a robust
commitment of the bSG/ mutant to the skeletal phenotype, as
revealed by our previous molecular characterization [12]. Such a
commitment was totally absent in WT cMabs and in bSG/ cMabs
after rescue (by miRNA699a transduction); thus, it can be considered
specific of the mutant genotype. At variance with previous studies [9,
21], we were unable to differentiate WT cMabs into cardiac myocytes.
This observation is consistent with the evidence that transduction of
bSG/ cMabs with miRNA669a, aimed to rescue the effects of bSG
deletion, prevented skeletal differentiation but, at least in vitro, it failed
to reinstate cardiac one [12]. Thus, our conclusions must be limited
to indicate that the bSG gene may encode a suppressor of skeletal
muscle differentiation, whose activity is mediated by miRNA669a.
Considering the uniformity of conditions (cMabs source, culture con-
ditions, etc.) inconsistency of cardiac differentiation of WT cMabs
between the present and previous studies [12, 21] has no obvious
explanation. In particular, because bSG/ and WT cMabs were stud-
ied after the same number of passages (see methods), cell ageing
cannot be responsible for the discrepancy.
Even if sharing features typical of skeletal muscle, bSG/ and
C2C12 myotubes were found to differ under several, more subtle,
aspects. As compared with C2C12 myotubes, bSG/ ones had (1)
larger variability in repolarization, presence of AP subpopulations with
a discernible plateau phase; (2) higher frequency of elementary Ca2+
release events, which included more than one amplitude class and
occurred as sparks and embers within the same release site; (3)
absence of RyR3 expression; (4) slower depletion of Ca2+ store by
repeated excitations.
Whereas the presence of a plateau phase is distinctive of adult
cardiac muscle in larger mammals, in murine cardiomyocytes bipha-
sic repolarization is limited to the foetal/neonatal stage and might
indicate incomplete expression of Ito, a repolarizing current appearing
Fig. 7 Elementary Ca2+ release events.
Examples of elementary Ca2+ release
events recorded from quiescent bSG/,
C2C12 myotubes and CM; Top: 3D repre-
sentation of line-scan images. Middle: ori-
ginal-line-scan images in colour scale
(right); Bottom: [Ca2+] time course of the
events shown in the middle panel (embers
and sparks, see text for definitions).
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late during myocyte maturation [15, 22]. Nevertheless, as repolariza-
tion of C2C12 myotubes was consistently monotonic, the observation
of biphasic repolarization in a subset of bSG/ myotubes might
point to persistence of a cardiac trait in an otherwise skeletal pheno-
type. As ICaL is the main current supporting the AP plateau, biphasic
repolarization might depend on partial persistence of its cardiac iso-
form. However, in bSG/ myotubes ICaL kinetics and the Ca
2+ chan-
nel isoform expression were typically ‘skeletal’. Moreover, Cav1.2
channel expression, obvious in CMs, could not be detected in bSG/
(Fig. 5e and f).
A higher frequency of elementary Ca2+ release events has been
previously reported in skeletal myocytes from dystrophin knock-
out mice and has been related to structural instability of the ‘junc-
tional’ space, formed by the juxtaposition of sarcolemmal and SR
membranes [23–25]. bSG belongs to the dystrophin complex and
myocytes from bSG/ mice are mechanically weaker [12, 26].
Therefore, rather than reflecting a variation from the skeletal pat-
tern, the abundance of spontaneous Ca2+ releases might be a
direct consequence of bSG gene deletion on membrane mechani-
cal stability.
The absence of RyR3 expression and slower depletion upon
repeated excitations might be causally related. Indeed RyR3 chan-
nels are supposed to amplify VICR by adding a CICR component
[27, 28]. Therefore, RyR3 expression might increase the fraction of
SR Ca2+ content released by a single excitation. Interestingly, in
mammalian skeletal muscle RyR3 are expressed in immature myo-
cytes only, where they are thought to account for the larger inci-
dence of spontaneous Ca2+ release events. [29]. Thus, at least
according to the lack of RyR3 expression, bSG/ myotubes might
appear as more mature than C2C12 ones. As opposed to RyR1,
RyR3 is reported to mediate brief events [28, 30]; interestingly,
release sites with brief events only were absent in bSG/ myotu-
bes. Caffeine elicited large Ca2+ transients even when applied shortly
after repeated depolarizations (by high K+ or nicotine) seemingly
exhausting the releasable Ca2+ pool (Fig. 6b). This observation is
consistent with previous reports in C2C12 myotubes, in which the
finding was interpreted as the presence caffeine-releasable Ca2+ pool
not accessible to VICR operation [19]. The occurrence of this phe-
nomenon also in bSG/ myotubes, which do not express RyR3,
may suggest the presence in these cells of a RyR1 population
uncoupled from membrane voltage sensing.
Conclusions
The present findings lead to conclude that deletion of the bSG encod-
ing gene, which includes the miRNA699a/q sequences, removes an
inhibitory control on cMabs differentiation towards a skeletal func-
tional phenotype. Rescue of deletion effects by transduction of miR-
NA699a suggests that the latter is involved in the inhibitory control.
These findings provide a functional counterpart to the previously
reported role of miRNA699a in preventing skeletal-type gene expres-
sion in cMabs [12]. Although previously reported commitment of
wild-type cMabs to myocardial differentiation [8, 9, 12] could not be
reproduced in this study, subtler aspects of bSG/ cMabs function
might suggest persistence of such a commitment.
Acknowledgements
This work was funded by Grant CARIPLO 2007. Dr Altomare fellowship was
supported by NEDD funding to A.Zaza.
Author contributions
Conception and design of the experiments (Altomare C, Zaza A, Roc-
chetti M). Collection, analysis and interpretation of data (Altomare C,
Sala L, Zaza A, Crippa S, Barile L). Drafting the article or revising it
critically for important intellectual content (Zaza A, Sampaolesi M). All
authors approved the final version of the manuscript.
Conflict of interest
No conflict of interest to be declared for this topic.
Supporting information
Additional Supporting Information may be found in the online
version of this article:
Data S1 Expanded materials and methods.
References
1. Beltrami AP, Barlucchi L, Torella D, et al.
Adult cardiac stem cells are multipotent and
support myocardial regeneration. Cell. 2003;
114: 763–76.
2. Messina E, De Angelis L, Frati G, et al. Iso-
lation and expansion of adult cardiac stem
cells from human and murine heart. Cir Res.
2004; 95: 911–21.
3. Smith RR, Barile L, Cho HC, et al. Regener-
ative potential of cardiosphere-derived cells
expanded from percutaneous endomyocardi-
al biopsy specimens. Circulation. 2007; 115:
896–908.
4. Urbanek K, Quaini F, Tasca G, et al.
Intense myocyte formation from cardiac
stem cells in human cardiac hypertrophy.
Proc Natl Acad Sci USA. 2003; 100:
10440–5.
5. Minasi MG, Riminucci M, De Angelis L,
et al. The meso-angioblast: a multipotent,
self-renewing cell that originates from the
dorsal aorta and differentiates into most
mesodermal tissues. Development. 2002;
129: 2773–83.
6. Dellavalle A, Sampaolesi M, Tonlorenzi
R, et al. Pericytes of human skeletal mus-
cle are myogenic precursors distinct from
satellite cells. Nat Cell Biol. 2007; 9: 255–
67.
7. Sampaolesi M, Blot S, D’Antona G, et al.
Mesoangioblast stem cells ameliorate mus-
cle function in dystrophic dogs. Nature.
2006; 444: 574–9.
ª 2013 The Authors
Journal of Cellular and Molecular Medicine Published by Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
427
J. Cell. Mol. Med. Vol 17, No 3, 2013
8. Galvez BG, Sampaolesi M, Barbuti A, et al.
Cardiac mesoangioblasts are committed,
self-renewable progenitors, associated with
small vessels of juvenile mouse ventricle.
Cell Death Differ. 2008; 15: 1417–28.
9. Barbuti A, Galvez BG, Crespi A, et al. Meso-
angioblasts from ventricular vessels can dif-
ferentiate in vitro into cardiac myocytes with
sinoatrial-like properties. J Mol Cell Cardiol.
2010; 48: 415–23.
10. Blake DJ, Weir A, Newey SE, et al. Function
and genetics of dystrophin and dystrophin-
related proteins in muscle. Physiol Rev.
2002; 82: 291–329.
11. Durbeej M, Cohn RD, Hrstka RF, et al. Dis-
ruption of the beta-sarcoglycan gene reveals
pathogenetic complexity of limb-girdle mus-
cular dystrophy type 2E. Mol Cell. 2000; 5:
141–51.
12. Crippa S, Cassano M, Messina G, et al.
miR669a and miR669q prevent skeletal
muscle differentiation in postnatal cardiac
progenitors. J Cell Biol. 2011; 193: 1197–
212.
13. Liang R, Bates DJ, Wang E. Epigenetic con-
trol of microRNA expression and aging. Curr
Genomics. 2009; 10: 184–93.
14. Tonlorenzi R, Dellavalle A, Schnapp E,
et al. Isolation and characterization of mes-
oangioblasts from mouse, dog, and human
tissues. Curr Protoc Stem Cell Biol. 2007;
Chapter 2: Unit 2B.1. doi: 10.1002/97804
70151808.sc02b01s3.
15. Nuss HB, Marban E. Electrophysiological
properties of neonatal mouse cardiac myo-
cytes in primary culture. J Physiol. 1994;
479(Pt 2): 265–79.
16. Altomare C, Barile L, Marangoni S, et al.
Caffeine-induced Ca(2+) signaling as an
index of cardiac progenitor cells differentia-
tion. Basic Res Cardiol. 2010; 105: 737–49.
17. Picht E, Zima AV, Blatter LA, et al. Spark-
Master: automated calcium spark analysis
with ImageJ. Am J Physiol Cell Physiol.
2007; 293: C1073–81.
18. Kimura I. Calcium-dependent desensitizing
function of the postsynaptic neuronal-type
nicotinic acetylcholine receptors at the neu-
romuscular junction. Pharmacol Ther. 1998;
77: 183–202.
19. Lorenzon P, Grohovaz F, Ruzzier F. Voltage-
and ligand-gated ryanodine receptors are
functionally separated in developing C2C12
mouse myotubes. J Physiol. 2000; 525(Pt
2): 499–507.
20. Kirsch WG, Uttenweiler D, Fink RH. Spark-
and ember-like elementary Ca2+ release
events in skinned fibres of adult mammalian
skeletal muscle. J Physiol. 2001; 537: 379–
89.
21. Galvez BG, Covarello D, Tolorenzi R, et al.
Human cardiac mesoangioblasts isolated
from hypertrophic cardiomyopathies are
greatly reduced in proliferation and differen-
tiation potency. Cardiovasc Res. 2009; 83:
707–16.
22. Xu H, Dixon JE, Barry DM, et al. Develop-
mental analysis reveals mismatches in the
expression of K+ channel alpha subunits
and voltage-gated K+ channel currents in rat
ventricular myocytes. J Gen Physiol. 1996;
108: 405–19.
23. Teichmann MD, Wegner FV, Fink RH, et al.
Inhibitory control over Ca(2+) sparks via
mechanosensitive channels is disrupted in
dystrophin deficient muscle but restored by
mini-dystrophin expression. PLoS ONE.
2008; 3: e3644.
24. Wang X, Weisleder N, Collet C, et al.
Uncontrolled calcium sparks act as a dystro-
phic signal for mammalian skeletal muscle.
Nat Cell Biol. 2005; 7: 525–30.
25. Weisleder N, Ma JJ. Ca2+ sparks as a plastic
signal for skeletal muscle health, aging, and
dystrophy. Acta Pharmacol Sin. 2006; 27:
791–8.
26. Carmignac V, Durbeej M. Cell-matrix inter-
actions in muscle disease. J Pathol. 2012;
226: 200–18.
27. Fessenden JD, Wang Y, Moore RA, et al.
Divergent functional properties of ryanodine
receptor types 1 and 3 expressed in a
myogenic cell line. Biophys J. 2000; 79:
2509–25.
28. Ward CW, Protasi F, Castillo D, et al.
Type 1 and type 3 ryanodine receptors
generate different Ca(2+) release event
activity in both intact and permeabilized
myotubes. Biophys J. 2001; 81: 3216–
30.
29. Legrand C, Giacomello E, Berthier C, et al.
Spontaneous and voltage-activated Ca2+
release in adult mouse skeletal muscle fibres
expressing the type 3 ryanodine receptor. J
Physiol. 2008; 586: 441–57.
30. Pouvreau S, Royer L, Yi J, et al. Ca(2+)
sparks operated by membrane
depolarization require isoform 3 ryanodine
receptor channels in skeletal muscle.
Proc Natl Acad Sci USA. 2007; 104:
5235–40.
428 ª 2013 The Authors
Journal of Cellular and Molecular Medicine Published by Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
